U.S. Markets closed

The BELLUS Health (TSE:BLU) Share Price Gained 1027% And Shareholders Are Jubilant

Simply Wall St

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Mistakes are inevitable, but a single top stock pick can cover any losses, and so much more. Take, for example, the BELLUS Health Inc. (TSE:BLU) share price, which skyrocketed 1027% over three years. It's down 1.6% in the last seven days.

It really delights us to see such great share price performance for investors.

Check out our latest analysis for BELLUS Health

BELLUS Health recorded just CA$35,000 in revenue over the last twelve months, which isn't really enough for us to consider it to have a proven product. So it seems that the investors focused more on what could be, than paying attention to the current revenues (or lack thereof). For example, they may be hoping that BELLUS Health comes up with a great new product, before it runs out of money.

Companies that lack both meaningful revenue and profits are usually considered high risk. There is usually a significant chance that they will need more money for business development, putting them at the mercy of capital markets. So the share price itself impacts the value of the shares (as it determines the cost of capital). While some such companies go on to make revenue, profits, and generate value, others get hyped up by hopeful naifs before eventually going bankrupt. BELLUS Health has already given some investors a taste of the sweet gains that high risk investing can generate, if your timing is right.

When it last reported its balance sheet in September 2019, BELLUS Health could boast a strong position, with cash in excess of all liabilities of CA$123m. That allows management to focus on growing the business, and not worry too much about raising capital. And with the share price up 27% per year, over 3 years , the market is focussed on that blue sky potential. The image below shows how BELLUS Health's balance sheet has changed over time; if you want to see the precise values, simply click on the image. The image below shows how BELLUS Health's balance sheet has changed over time; if you want to see the precise values, simply click on the image.

TSX:BLU Historical Debt, December 2nd 2019

It can be extremely risky to invest in a company that doesn't even have revenue. There's no way to know its value easily. One thing you can do is check if company insiders are buying shares. It's often positive if so, assuming the buying is sustained and meaningful. Luckily we are in a position to provide you with this free chart of insider buying (and selling).

A Different Perspective

We're pleased to report that BELLUS Health shareholders have received a total shareholder return of 149% over one year. That's better than the annualised return of 15% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought. You can find out about the insider purchases of BELLUS Health by clicking this link.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.